Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity
Clinical trial NCT02896192 · COMPLETED
Trial details
- NCT number
- NCT02896192
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2020-05-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.